TNF and rheumatoid arthritis: Although conventional synthetic DMARDs are effective, the introduction of the second category, biologic DMARDs, in the form of TNFα inhibitors in the late 1990s has been hailed as a watershed moment in the history of the RA treatment [10,74,76,77].